Friedberg JW, Bordoni R, Patel-Donnelly D, et al. Brentuximab vedotin with dacarbazine or nivolumab as frontline cHL therapy for older patients ineligible for chemotherapy. Blood. 2024;143(9):786-795
- PMID: 39388158
- DOI: 10.1182/blood.2024026833
Friedberg JW, Bordoni R, Patel-Donnelly D, et al. Brentuximab vedotin with dacarbazine or nivolumab as frontline cHL therapy for older patients ineligible for chemotherapy. Blood. 2024;143(9):786-795
Erratum for
-
Brentuximab vedotin with dacarbazine or nivolumab as frontline cHL therapy for older patients ineligible for chemotherapy.Blood. 2024 Feb 29;143(9):786-795. doi: 10.1182/blood.2022019536. Blood. 2024. PMID: 37946283 Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources
